Parla, Spain

Longfei Xie

This inventor holds 1 USPTO granted patent. Top assignee: Chinese Academy of Sciences. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Longfei Xie. Retrieved from https://idiyas.com/inventor/longfei-xie-eqyc9nr3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Longfei Xie: Innovator in Pharmaceutical Chemistry

Introduction

Longfei Xie is a prominent inventor based in Parla, Spain. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative research on coumarin derivatives. His work focuses on developing new drug compositions aimed at treating various health conditions.

Latest Patents

Longfei Xie holds 1 patent for his invention titled "Coumarin-amide derivatives and its preparation, said drug composition and its use." This patent relates to novel coumarin derivatives and their carboxamides, which are utilized in pharmaceutical compositions. These compositions are designed for kidney protection and the treatment of hypertension, cardio-cerebrovascular diseases, non-insulin dependent diabetes, tumors, pre-cancerous lesions, and edemas.

Career Highlights

Longfei Xie is affiliated with the Chinese Academy of Sciences, where he conducts his research and development activities. His work has garnered attention for its potential impact on public health and the treatment of chronic diseases.

Collaborations

He has collaborated with notable colleagues, including Song Xu and Shiping Xu, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Longfei Xie's contributions to pharmaceutical chemistry exemplify the importance of innovation in developing effective treatments for various health conditions. His work continues to inspire advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…